Figure 2
Forest plots for (A) thrombolysis in myocardial infarction major bleeding and (B) thrombolysis in myocardial infarction major in combination with thrombolysis in myocardial infarction minor bleeding are shown with standard errors of the treatment effect and calculated hazard ratio with corresponding 95% confidence interval. In (B), the PIONEER AF-PCI trial also included trial-defined clinically significant bleeding in the analysis. CI, confidence interval; DAT, dual antithrombotic therapy; HR, hazard ratio; IV, inverse variance; SE, standard error; TAT, triple antithrombotic therapy; TE, treatment effect; TIMI, thrombolysis in myocardial infarction.

Forest plots for (A) thrombolysis in myocardial infarction major bleeding and (B) thrombolysis in myocardial infarction major in combination with thrombolysis in myocardial infarction minor bleeding are shown with standard errors of the treatment effect and calculated hazard ratio with corresponding 95% confidence interval. In (B), the PIONEER AF-PCI trial also included trial-defined clinically significant bleeding in the analysis. CI, confidence interval; DAT, dual antithrombotic therapy; HR, hazard ratio; IV, inverse variance; SE, standard error; TAT, triple antithrombotic therapy; TE, treatment effect; TIMI, thrombolysis in myocardial infarction.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close